A case of Candida krusei peritonitis secondary to duodenal perforation due to Candida duodenitis.
A case of a 62-year-old man with Candida krusei peritonitis secondary to duodenal perforation due to Candida duodenitis that was successfully treated with a 14-day course of caspofungin is reported. The potential role of Candida infection in the pathogenesis of peptic ulcers and duodenal perforation is considered. If this role is confirmed, antifungal treatment should be included in the therapeutic armamentarium of peptic disease.
Cascio
Antonio
A
Tropical and Parasitological Diseases Unit, Department of Human Pathology, University of Messina, Messina, Italy. acascio@unime.it
Bartolotta
Marcello
M
Venneri
Antonella
A
Musolino
Cinzia
C
Iaria
Chiara
C
Delfino
Demetrio
D
Navarra
Giuseppe
G
D000935:Antifungal Agents / Q000008:administration & dosage; D002175:Candida / Q000302:isolation & purification*; D002177:Candidiasis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D000077336:Caspofungin; D004378:Duodenal Diseases / Q000150:complications*; D054714:Echinocandins / Q000008:administration & dosage; D006801:Humans; D007416:Intestinal Perforation / Q000150:complications*; D055666:Lipopeptides; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000150:complications*; D010538:Peritonitis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D016896:Treatment Outcome
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D000077336:Caspofungin